Interobserver Reproducibility of PD-L1 Biomarker in Non-small Cell Lung Cancer: A Multi-Institutional Study by 27 Pathologists

Background Assessment of programmed cell death-ligand 1 (PD-L1) immunohistochemical staining is used for treatment decisions in non-small cell lung cancer (NSCLC) regarding use of PD-L1/programmed cell death protein 1 (PD-1) immunotherapy. The reliability of the PD-L1 22C3 pharmDx assay is critical...

Full description

Bibliographic Details
Main Authors: Sunhee Chang, Hyung Kyu Park, Yoon-La Choi, Se Jin Jang
Format: Article
Language:English
Published: Korean Society of Pathologists & the Korean Society for Cytopathology 2019-11-01
Series:Journal of Pathology and Translational Medicine
Subjects:
Online Access:http://www.jpatholtm.org/upload/pdf/jptm-2019-09-29.pdf